HTLV-1 infection and health outcomes - 27/03/20
Doi : 10.1016/S1473-3099(20)30133-X
José-Manuel Ramos a, b, Carmen de Mendoza c, d, e, Vicente Soriano f 
on behalf of the

on behalf of the
Spanish HTLV Network
a Internal Medicine Department, General University Hospital of Alicante, Alicante, Spain
b Infectious Disease Unit, Miguel Hernandez University, Elche, Spain
c Laboratory of Internal Medicine, Puerta de Hierro Research Institute, Madrid, Spain
d Internal Medicine Department, Puerta de Hierro University Hospital, Madrid Spain
e Microbiology Department, San Pablo-CEU University, Madrid, Spain
f UNIR Health Sciences School and Medical Center, Madrid 28040, Spain
Le texte complet de cet article est disponible en PDF.
© 2020
Elsevier Ltd. Tous droits réservés.
Vol 20 - N° 4
P. 407-408 - avril 2020 Retour au numéroDéjà abonné à cette revue ?


